Abstract
Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and this article considers its potential mechanisms for action in either a pro- or anti-viral manner. It is evident that more experimental work is required; however, PARP14 appears vital in controlling the interferon response to the SARS-CoV-2 infection and has potential roles in balancing the proinflammatory cytokines of the cytokine storm. Furthermore, the SARS-CoV-2 macrodomain can prevent the PARP14-mediated antiviral response, suggesting a more complex relationship between PARP14 activity and SARS-CoV-2 infections.
| Original language | English |
|---|---|
| Pages (from-to) | 587-592 |
| Number of pages | 6 |
| Journal | Future Medicinal Chemistry |
| Volume | 13 |
| Issue number | 6 |
| Early online date | 20 Jan 2021 |
| DOIs | |
| Publication status | Published - Mar 2021 |
Fingerprint
Dive into the research topics of 'The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)'. Together they form a unique fingerprint.Related Research Outputs
- 10 Citations
- 1 Article
-
The connection between PARP14 and SARS-CoV-2
Tauber, A. L., Schweiker, S. S. & Levonis, S. M., 1 Feb 2023, In: Future Medicinal Chemistry. 15, 3, p. 225-227 3 p.Research output: Contribution to journal › Article › Research › peer-review
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver